• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunotherapy of cancer using interleukin 2: current status and future prospects.

作者信息

Rosenberg S A

出版信息

Immunol Today. 1988 Feb;9(2):58-62. doi: 10.1016/0167-5699(88)91261-3.

DOI:10.1016/0167-5699(88)91261-3
PMID:3076761
Abstract
摘要

相似文献

1
Immunotherapy of cancer using interleukin 2: current status and future prospects.使用白细胞介素-2进行癌症免疫治疗：现状与未来前景
Immunol Today. 1988 Feb;9(2):58-62. doi: 10.1016/0167-5699(88)91261-3.
2
Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.利用淋巴因子激活的杀伤细胞和重组白细胞介素-2进行癌症的过继性免疫治疗。
Important Adv Oncol. 1986:55-91.
3
[Use of interleukin 2-activated lymphocytes (LAK cells) in adoptive immunotherapy of neoplasms].[白细胞介素2激活的淋巴细胞（LAK细胞）在肿瘤过继性免疫治疗中的应用]
Pol Tyg Lek. 1988 Nov 21;43(47):1491-5.
4
Adoptive immunotherapy in gastrointestine malignancies using interleukin-2. Current results and future prospects.使用白细胞介素-2的胃肠道恶性肿瘤过继性免疫疗法。当前结果与未来前景。
Acta Chir Scand Suppl. 1989;549:71-4.
5
[Prospects for cancer immunotherapy using interleukin-1(IL-1) and interleukin-2(IL-2)].使用白细胞介素-1（IL-1）和白细胞介素-2（IL-2）进行癌症免疫治疗的前景
Nihon Rinsho. 1983;41(4):868-74.
6
Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.淋巴因子激活的杀伤细胞：癌症免疫治疗的新方法。
J Natl Cancer Inst. 1985 Oct;75(4):595-603.
7
[Adoptive immunotherapy: a new therapeutic approach to cancer based on interleukin 2].[过继性免疫疗法：一种基于白细胞介素-2的癌症新治疗方法]
Rev Med Brux. 1987 Mar;8(3):133-9.
8
[Interleukin 2].[白细胞介素2]
Gan To Kagaku Ryoho. 1987 May;14(5 Pt 1):1203-7.
9
Immunotherapy of cancer: the end of the beginning?癌症免疫疗法：开端的结束？
N Engl J Med. 1987 Apr 9;316(15):939-41. doi: 10.1056/NEJM198704093161509.
10
Natural killer cell-based immunotherapy in cancer: current insights and future prospects.基于自然杀伤细胞的癌症免疫疗法：当前见解与未来展望。
J Intern Med. 2009 Aug;266(2):154-81. doi: 10.1111/j.1365-2796.2009.02121.x.

引用本文的文献

1
Role of Sonification and Rhythmic Auditory Cueing for Enhancing Gait Associated Deficits Induced by Neurotoxic Cancer Therapies: A Perspective on Auditory Neuroprosthetics.超声化和节律性听觉提示对改善神经毒性癌症治疗引起的步态相关缺陷的作用：听觉神经假体的视角
Front Neurol. 2019 Jan 29;10:21. doi: 10.3389/fneur.2019.00021. eCollection 2019.
2
Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.在严重联合免疫缺陷（SCID）小鼠异种移植模型中，过继转移的人肺肿瘤特异性细胞毒性T细胞可以控制自体肿瘤生长并塑造肿瘤表型。
J Transl Med. 2007 Jun 25;5:29. doi: 10.1186/1479-5876-5-29.
3
Life-prolonging effect of immunocell BAK (BRM-activated killer) therapy for advanced solid cancer patients: prognostic significance of serum immunosuppressive acidic protein levels.
免疫细胞BAK（生物反应调节剂激活的杀伤细胞）疗法对晚期实体癌患者的延长生命作用：血清免疫抑制酸性蛋白水平的预后意义
Cancer Immunol Immunother. 2003 Sep;52(9):555-60. doi: 10.1007/s00262-003-0393-8.
4
Activation of preexisting T cell clones by targeted interleukin 2 therapy.通过靶向白细胞介素-2疗法激活预先存在的T细胞克隆。
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8785-90. doi: 10.1073/pnas.95.15.8785.
5
Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.头颈部鳞状细胞癌淋巴结转移灶中MET癌基因/肝细胞生长因子受体的检测
Eur Arch Otorhinolaryngol. 1997;254 Suppl 1:S138-43. doi: 10.1007/BF02439745.
6
The cytocidal activity of OK-432-activated mononuclear cells against human glioma cells is partly mediated through the Fas ligand/Fas system.OK-432激活的单核细胞对人胶质瘤细胞的杀细胞活性部分是通过Fas配体/Fas系统介导的。
Jpn J Cancer Res. 1996 Sep;87(9):972-6. doi: 10.1111/j.1349-7006.1996.tb02128.x.
7
Immunomodulation following chemotherapy.化疗后的免疫调节
Breast Cancer Res Treat. 1996;38(1):41-8. doi: 10.1007/BF01803782.
8
Clonal analysis of peripheral blood lymphocytes from three patients with advanced neuroblastoma receiving recombinant interleukin-2 and interferon alpha.对三名接受重组白细胞介素-2和干扰素α治疗的晚期神经母细胞瘤患者外周血淋巴细胞的克隆分析。
Cancer Immunol Immunother. 1993 Jul;37(1):40-6. doi: 10.1007/BF01516940.
9
Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking.用经流体静压和化学交联修饰的细胞接种的小鼠中诱导针对B16-BL6黑色素瘤的细胞介导免疫。
Cancer Immunol Immunother. 1993 May;36(5):300-6. doi: 10.1007/BF01741168.
10
The possible use of spleen cells for the adoptive immunotherapy of cancer patients.脾细胞在癌症患者过继性免疫治疗中的潜在应用。
Surg Today. 1993;23(1):13-20. doi: 10.1007/BF00308994.